Certara stock had its Relative Strength (RS) Rating upgraded from 80 to 87 Monday.
Risk Management In The Stock Market: How Much Money To Invest Now
IBD's proprietary RS Rating identifies market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock's price action over the last 52 weeks matches up against that of all other stocks.
Decades of market research shows that the market's biggest winners tend to have an 80 or better RS Rating as they begin their biggest climbs.
Is Certara Stock A Buy?
Certara stock is building a cup without handle with a 15.69 buy point. This is not the time to buy stocks during a market selloff, but build a watchlist of possible emerging leaders once the market trend turns around.
In terms of top and bottom line numbers, the company has posted two quarters of accelerating earnings growth. Sales growth has also risen during the same period. The computer software company is expected to release its next quarterly numbers on or around May 1.
Certara stock holds the No. 4 rank among its peers in the Computer Software-Medical industry group. Doximity is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
